Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Biotech
JPM26, Day 1: Updates from Lilly, Takeda, Novartis and Sofinnova
The life sciences world is once again converging in San Francisco as 2026's JPM kicks off, with Fierce tracking the biggest stories as they happen.
Gabrielle Masson
,
James Waldron
,
Darren Incorvaia
,
Ben Adams
Jan 12, 2026 6:59pm
Lilly, Nvidia form new AI co-innovation lab with $1B investment
Jan 12, 2026 10:00am
Lilly buys inflammation biotech Ventyx for $1.2B
Jan 8, 2026 7:01am
InduPro nabs 2nd Big Pharma deal with $950M Lilly pact
Jan 7, 2026 3:52pm
Lilly returns to Nimbus in $1.3B deal to create oral obesity med
Jan 6, 2026 10:05am
Neuro biotech Nido closes after 5 years
Jan 2, 2026 10:24am